Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

30. April 2026 12:19 ET | Quelle: Research and Markets

Contract Research and Manufacturing Services (CRAMS) Research Report 2026: $258.36 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, April 30, 2026 (GLOBE NEWSWIRE) -- The "Contract Research and Manufacturing Services (CRAMS) Market Report 2026" has been added to ResearchAndMarkets.com's offering. The Contract...
30. April 2026 12:00 ET | Quelle: Research and Markets

Pharmaceutical Contract Development and Manufacturing Organization (CDMO) for Formulations Market Research Report 2026: Opportunities, Trends, Competitive Landscape, Strategies, Forecasts 2020-2035

Dublin, April 30, 2026 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Development and Manufacturing Organization (CDMO) for Formulations Market Report 2026" has been added to ...
30. April 2026 11:54 ET | Quelle: Research and Markets

Peptide and Oligonucleotide CDMO Market Research Report 2026: $4+ Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, April 30, 2026 (GLOBE NEWSWIRE) -- The "Peptide and Oligonucleotide CDMO Market Report 2026" has been added to ResearchAndMarkets.com's offering. The peptide and oligonucleotide DMO...
30. April 2026 06:41 ET | Quelle: Research and Markets

Biopharmaceutical CMO Market Analysis Report 2026: $54.54 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, April 30, 2026 (GLOBE NEWSWIRE) -- The "Biopharmaceutical CMO Market Report 2026" has been added to ResearchAndMarkets.com's offering. The biopharmaceutical CMO market has experienced...
29. April 2026 09:59 ET | Quelle: Research and Markets

2 Day Virtual FDA and EU Annex 15 Process Validation Guidance & Requirements Training Course (LIVE EVENT & ON-DEMAND: June 24th - June 25th, 2026)

Dublin, April 29, 2026 (GLOBE NEWSWIRE) -- The "Process Validation Guidance & Requirements Training Course (June 24th - June 25th, 2026)" training has been added to ResearchAndMarkets.com's...
15. April 2026 10:12 ET | Quelle: Research and Markets

Biotechnology for the Non-Biotechnologist Course: How Biotech Products are Being Developed and Manufactured, and Discussion on the Scientific and Regulatory Environment (ONLINE EVENT)

Dublin, April 15, 2026 (GLOBE NEWSWIRE) -- The "Biotechnology for the Non-Biotechnologist (June 10th - June 12th, 2026)" training has been added to ResearchAndMarkets.com's offering.This intensive...
09. April 2026 06:05 ET | Quelle: Research and Markets

$1.05 Bn Biopharmaceutical CXO Markets - Global Forecast Report 2026-2032: How Leading Pharmas Such as Pfizer, Roche, Novartis, Sanofi, and AstraZeneca Navigate the Evolving Dynamics

Dublin, April 09, 2026 (GLOBE NEWSWIRE) -- The "Biopharmaceutical CXO Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. The Biopharmaceutical CXO...
09. April 2026 05:09 ET | Quelle: Research and Markets

Active Pharmaceutical Ingredients CDMO Market Research and Global Forecast Report 2025-2032: Exploring Service Models, Analytical Services, Process Developments, and More

Dublin, April 09, 2026 (GLOBE NEWSWIRE) -- The "Active Pharmaceutical Ingredients CDMO Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. The Active...
09. März 2026 09:00 ET | Quelle: AsymBio

AsymBio Completes its Dual-Site, One-Center Network with Fengxian Commercial Manufacturing Site Operational, Enhancing End-to-End Biologics CDMO Capabilities

SHANGHAI, March 09, 2026 (GLOBE NEWSWIRE) -- AsymBio, a subsidiary of Asymchem Group (stock code: 002821.SZ /6821.HK), recently announced that its Fengxian commercial manufacturing site in Shanghai...
03. März 2026 04:24 ET | Quelle: Research and Markets

AI in Pharma Manufacturing Market Research 2026-2040: Pfizer, Moderna, Novartis, Merck, and Sanofi are Integrating AI Into Their Operations As the Sector Evolves Towards Pharma 4.0

Dublin, March 03, 2026 (GLOBE NEWSWIRE) -- The "AI in Pharma Manufacturing Market, till 2040: Distribution by Type of Offering, Mode of Deployment, Type of AI Solution, Type of Technology,...

Nächste Seite